Thermo Fisher Scientific, Inc. (TMO)

NYSE: TMO · IEX Real-Time Price · USD
563.00
-1.56 (-0.28%)
At close: Dec 2, 2022 4:00 PM
563.24
+0.24 (0.04%)
Pre-market: Dec 5, 2022 4:01 AM EST
-0.28%
Market Cap 221.42B
Revenue (ttm) 44.17B
Net Income (ttm) 7.03B
Shares Out 392.00M
EPS (ttm) 17.79
PE Ratio 31.65
Forward PE 23.92
Dividend $1.16 (0.21%)
Ex-Dividend Date Dec 14, 2022
Volume 947,459
Open 553.54
Previous Close 564.56
Day's Range 550.28 - 564.8
52-Week Range 475.77 - 672.34
Beta 0.83
Analysts Buy
Price Target 630.39 (+12.0%)
Earnings Date Oct 26, 2022

About TMO

Thermo Fisher Scientific Inc. offers life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and service worldwide. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as diagnosis of infections and diseases to pharmaceutical, biotechnology, agricultural, clinical, healthcare, academic, and government markets. Its Analytical Instruments segment provides instruments, consuma... [Read more]

Industry Life Sciences Tools & Services
Founded 1956
CEO Marc Casper
Employees 130,000
Stock Exchange NYSE
Ticker Symbol TMO
Full Company Profile

Financial Performance

In 2021, TMO's revenue was $39.21 billion, an increase of 21.71% compared to the previous year's $32.22 billion. Earnings were $7.73 billion, an increase of 21.18%.

Financial Statements

Analyst Forecast

According to 30 analysts, the average rating for TMO stock is "Buy." The 12-month stock price forecast is 630.39, which is an increase of 11.97% from the latest price.

Price Target
$630.39
(11.97% upside)
Analyst Consensus: Buy
Stock Forecasts

News

Thermo Fisher (TMO) Up 9.8% Since Last Earnings Report: Can It Continue?

Thermo Fisher (TMO) reported earnings 30 days ago. What's next for the stock?

1 week ago - Zacks Investment Research

Thermo Fisher Scientific to Present at Evercore ISI HealthCONx Conference

WALTHAM, Mass.--( BUSINESS WIRE )--Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, announced that Marc N. Casper, chairman, president and chief executive officer, will pr...

1 week ago - Business Wire

3 Unstoppable Growth Stocks to Buy and Hold

These businesses are built for the long run.

Other symbols: PFEVRTX
2 weeks ago - The Motley Fool

Thermo Fisher Scientific Introduces All-in-One AAV Production System for Scalable Gene Therapy Workflows and Commerci...

CARLSBAD, Calif.--( BUSINESS WIRE )--Thermo Fisher Scientific, the world leader in serving science, today introduced the Gibco CTS AAV-MAX Helper-Free AAV Production System, a new all-in-one solution de...

2 weeks ago - Business Wire

Thermo Fisher Scientific Prices Offering of Euro-Denominated Senior Notes

WALTHAM, Mass.--( BUSINESS WIRE )--Thermo Fisher Scientific Inc. (NYSE: TMO) (“Thermo Fisher”) announced today that on November 14, 2022 it priced an offering of €1.25 billion aggregate principal amount...

2 weeks ago - Business Wire

Thermo Fisher Scientific Prices Offering of USD-Denominated Senior Notes

WALTHAM, Mass.--( BUSINESS WIRE )--Thermo Fisher Scientific Inc. (NYSE: TMO) (“Thermo Fisher”) announced today that on November 14, 2022 it priced an offering of $1.2 billion aggregate principal amount ...

2 weeks ago - Business Wire

Thermo Fisher Scientific Authorizes $4 Billion of Share Repurchases

WALTHAM, Mass.--( BUSINESS WIRE )--Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today announced that its board of directors has authorized the repurchase of $4 billion...

3 weeks ago - Business Wire

Thermo Fisher Scientific Declares Quarterly Dividend

WALTHAM, Mass.--( BUSINESS WIRE )--Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today announced that its Board of Directors authorized a quarterly cash dividend of $0....

3 weeks ago - Business Wire

Thermo Fisher Scientific Showcases Pharma Services Innovation and Expertise at CPHI Frankfurt 2022

FRANKFURT, Germany--(BUSINESS WIRE)--This week at CPHI Frankfurt, Thermo Fisher Scientific will showcase its expertise, innovations and capabilities to help pharmaceutical and emerging biotech companies...

1 month ago - Business Wire

Thermo Fisher Makes Another Acquisition. Spends $2.6 Billion on Testing Company.

Binding Site builds medical instruments that help diagnose blood cancers and immune system disorders.

1 month ago - Barrons

Thermo Fisher Scientific to Acquire The Binding Site Group

WALTHAM, Mass.

1 month ago - Business Wire

Thermo Fisher (TMO) Q3 Earnings Top Estimates, Margins Down

Robust demand for Thermo Fisher's (TMO) laboratory products and biopharma services buoys optimism. However, lower Life Sciences Solutions segment revenues in the third quarter disappoint.

1 month ago - Zacks Investment Research

Thermo Fisher Scientific (TMO) Beats Q3 Earnings and Revenue Estimates

Thermo Fisher (TMO) delivered earnings and revenue surprises of 6.28% and 8.30%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?

1 month ago - Zacks Investment Research

Thermo Fisher Scientific Reports Third Quarter 2022 Results

WALTHAM, Mass.

1 month ago - Business Wire

Thermo Fisher Scientific demonstrates commitment to transplant patients and collaboration at ASHI 2022

LAS VEGAS--(BUSINESS WIRE)--Thermo Fisher Scientific, the world leader in serving science, will demonstrate the benefits of collaborating to advance the science of transplantation and connecting breakth...

1 month ago - Business Wire

Thermo Fisher Scientific (TMO) Expected to Beat Earnings Estimates: Should You Buy?

Thermo Fisher (TMO) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

1 month ago - Zacks Investment Research

Buying These 3 Stocks Could Be the Smartest Move You Ever Make

Look past all the noise and think about the bigger picture.

Other symbols: ASMLGOOGGOOGL
1 month ago - The Motley Fool

Why Thermo Fisher (TMO) Could Beat Earnings Estimates Again

Thermo Fisher (TMO) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

1 month ago - Zacks Investment Research

What's in Store for Thermo Fisher (TMO) in Q3 Earnings?

In terms of performance in high-growth and emerging markets, in its flagship facility for cell culture media in Grand Island, NY, Thermo Fisher (TMO) completes capacity expansion.

1 month ago - Zacks Investment Research

Thermo Fisher Scientific Named 2022 Eagle Award Winner for Clinical Research Site Partnerships

The PPD clinical research business of Thermo Fisher Scientific Inc., the world leader in serving science, has been awarded the Eagle Award for the second consecutive year for its outstanding leadership,...

1 month ago - Business Wire